Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus
10.1136/lupus-2021-000475
March 18, 2021
Biomarker Studies
RNA tape sampling in cutaneous lupus erythematosus discriminates affected from unaffected and healthy volunteer skin
10.1136/lupus-2020-000428
March 3, 2021
Different indirect immunofluorescence ANA substrate performance in a diagnostic setting of patients with SLE and related disorders: retrospective review and analysis
10.1136/lupus-2020-000431
November 5, 2020
Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus
10.1136/lupus-2020-000406
November 2, 2020
Loss of antiphospholipid antibody positivity post-thrombosis in SLE
10.1136/lupus-2020-000423
October 6, 2020
Glycosphingolipid-associated β-1,4 galactosyltransferase is elevated in patients with systemic lupus erythematosus
10.1136/lupus-2019-000368
July 13, 2020
Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
10.1136/lupus-2019-000375
June 15, 2020
Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus
10.1136/lupus-2019-000359
November 13, 2019
Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE
10.1136/lupus-2019-000349
September 19, 2019
Comparison of PREDICTS atherosclerosis biomarker changes after initiation of new treatments in patients with SLE
10.1136/lupus-2019-000321
June 27, 2019